Sg3 Management, LLC Astrazeneca PLC Call Options Transaction History

Sg3 Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $14 Million - $16.8 Million	-236,600 Reduced 71.59%	93,900 $6.2 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $17.8 Million - $21.4 Million	318,700 Added 2700.85%	330,500 $21.9 Million
Q4 2021 Feb 15, 2022	SELL	$54.02 - $63.83 $3.11 Million - $3.68 Million	-57,600 Reduced 83.0%	11,800 $687,000
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $2.26 Million - $2.47 Million	-40,600 Reduced 36.91%	69,400 $4.17 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $5.19 Million - $5.99 Million	110,000 New	110,000 $5.47 Million
Q2 2017 Jan 25, 2018	SELL	N/A	-30,600 Closed	0 $0
Q1 2017 Feb 26, 2018	BUY	N/A	30,294 Added 9900.0%	30,600 $953,000
Q1 2017 Jan 25, 2018	SELL	N/A	-4,694 Reduced 93.88%	306 $15,000
Q4 2016 Feb 23, 2018	BUY	N/A	4,950 Added 9900.0%	5,000 $137,000
Q4 2016 Jan 24, 2018	BUY	N/A	50	50 $4,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.